Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Rating of “Moderate Buy” from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has been assigned an average rating of “Moderate Buy” from the twelve research firms that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $35.6667.

Several research analysts have commented on the stock. Citizens Jmp decreased their target price on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating for the company in a research report on Friday, October 31st. JMP Securities set a $36.00 price objective on Option Care Health in a research report on Friday, October 31st. Morgan Stanley assumed coverage on Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective for the company. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st.

Option Care Health Stock Performance

Shares of OPCH opened at $30.59 on Tuesday. The firm has a fifty day moving average of $28.32 and a 200-day moving average of $29.29. The company has a market cap of $4.86 billion, a price-to-earnings ratio of 24.28, a price-to-earnings-growth ratio of 2.11 and a beta of 0.79. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. Option Care Health has a 1 year low of $22.29 and a 1 year high of $35.53.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Option Care Health

Several large investors have recently bought and sold shares of OPCH. Durable Capital Partners LP boosted its stake in Option Care Health by 134.2% during the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Norges Bank acquired a new stake in shares of Option Care Health in the second quarter valued at $69,932,000. Nuveen LLC acquired a new stake in shares of Option Care Health in the first quarter valued at $70,965,000. Swedbank AB bought a new position in Option Care Health during the third quarter valued at about $49,455,000. Finally, Arrowstreet Capital Limited Partnership grew its holdings in Option Care Health by 109.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock worth $110,770,000 after acquiring an additional 1,778,279 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.